Mylan Pharms Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for MYLAN PHARMS INC, and what generic and branded alternatives to MYLAN PHARMS INC drugs are available?
MYLAN PHARMS INC has forty-two approved drugs.
There are eighteen tentative approvals on MYLAN PHARMS INC drugs.
Drugs and US Patents for Mylan Pharms Inc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mylan Pharms Inc | METOPROLOL SUCCINATE | metoprolol succinate | TABLET, EXTENDED RELEASE;ORAL | 202033-002 | Dec 15, 2011 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Mylan Pharms Inc | RIZATRIPTAN BENZOATE | rizatriptan benzoate | TABLET;ORAL | 201993-002 | Dec 31, 2012 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Mylan Pharms Inc | DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE | doxylamine succinate; pyridoxine hydrochloride | TABLET, DELAYED RELEASE;ORAL | 207825-001 | Jul 6, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Mylan Pharms Inc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Mylan Pharms Inc | AVITA | tretinoin | CREAM;TOPICAL | 020404-003 | Jan 14, 1997 | 4,971,800 | ⤷ Sign Up |
Mylan Pharms Inc | AVITA | tretinoin | CREAM;TOPICAL | 020404-003 | Jan 14, 1997 | 5,045,317 | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.